HGF and endometrial cancer: In the report described above, we found that the levels of Met, Akt, and ERK phosphorylation were significantly decreased by foretinib treatment, suggesting that the PI3K/Akt and MAPK pathways are promoted via the HGF/Met signaling pathway in endometrial cancer cell lines.